Target intelligence / Profile preview

Free radicals and lipid peroxides (ROS/LPO)

Target
ROS/LPO
Molecular classification
Other
01

Overview

Free radicals and lipid peroxides represent a broad category of reactive chemical species that play dual roles as signaling molecules and mediators of cellular damage (Lobo et al., 2010; PMID: 22228951). Free radicals, such as superoxide and hydroxyl radicals, contain unpaired electrons that make them highly reactive toward biological macromolecules like DNA and proteins. Lipid peroxides are specific products of the oxidative degradation of polyunsaturated fatty acids in cell membranes; their accumulation is a hallmark of oxidative stress and serves as the primary driver of ferroptosis, a form of iron-dependent regulated cell death (Ayala et al., 2014; PMID: 24991264; Stockwell et al., 2017; PMID: 29053968). In physiological conditions, controlled levels of reactive species are involved in intracellular signaling pathways, but their overproduction leads to pathological states (Pizzino et al., 2017; PMID: 28819445). These species are implicated in the progression of diverse diseases, including neurodegenerative disorders (e.g., ALS), atherosclerosis, and chronic inflammation. Pharmacological interventions typically focus on neutralizing these species using antioxidant scavengers, such as Edaravone or N-acetylcysteine, or preventing their formation by modulating enzymatic pathways or chelating pro-oxidant metal ions.

Other names
Reactive oxygen speciesReactive nitrogen speciesLipid hydroperoxidesLipid peroxidation productsOxidantsReactive metabolites
02

Mechanism of action

Direct neutralization of reactive species through radical scavenging, electron donation, or enzymatic reduction to stable, non-toxic metabolites

03

Biological functions

Signal transductionCell deathApoptosisImmune responseFerroptosisOxidative stress induction
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerInflammationIschemia-reperfusion injuryAging
05

Safety considerations

Inhibition of essential physiological redox signaling required for cell adaptationPotential pro-oxidant effects in the presence of transition metalsPoor clinical translation due to low bioavailability at target sitesInterference with beneficial reactive species used by the immune system
06

Interacting drugs

Edaravone

8 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)8-Isoprostane (F2-isoprostanes)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonyls

Beyond the preview

Go deeper on Free radicals and lipid peroxides (ROS/LPO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free radicals and lipid peroxides (ROS/LPO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call